IHCH-3064

CAT: 0804-HY-145406Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-145406Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
IHCH-3064 is a dual-acting compounds targeting Adenosine A2A Receptor and HDAC. IHCH-3064 exhibits potent binding to A2AR (Ki=2.2 nM) and selective inhibition of HDAC1 (IC50=80.2 nM), with good antiproliferative activity against tumor cell lines in vitro. IHCH-3064 is a tumor immunotherapeutic agent.
CAS Number
[2420562-65-6]
UNSPSC
12352005
Target
Adenosine Receptor; HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics; GPCR/G Protein
Applications
COVID-19-anti-virus
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ihch-3064.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC=C(CCN2N=CC3=C2N=C(N)N4N=C(C5=CC=CO5)N=C34)C=C1)NC6=C(N)C=CC=C6
Molecular Formula
C25H21N9O2
Molecular Weight
479.49
References & Citations
[1]Wenzhong Yan, et al. Structure-Based Design of Dual-Acting Compounds Targeting Adenosine A 2A Receptor and Histone Deacetylase as Novel Tumor Immunotherapeutic Agents. J Med Chem. 2021 Nov 25;64 (22) :16573-16597.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-W077477-01IHCH-7113
HY-169841-01IHCH-7086
HY-176910IHCH-7179
HY-177814LJM-3064 (sodium)
HY-R02913A-01Mmu-miR-3064-3p agomir
HY-R00527A-01Hsa-miR-3064-3p agomir
HY-RI02913A-01Mmu-miR-3064-3p antagomir
HY-R04335A-01Rno-miR-3064-5p agomir
HY-R00527-01Hsa-miR-3064-3p mimic
HY-R02914A-01Mmu-miR-3064-5p agomir

Alternative Products

CatalogName
MBS5805825IHCH-3064
T202365-01IHCH-7086
mm0294AdmiRa-mmu-mir-3064 Virus
MPR00580rno-miR-3064-5p Primers
MPH02407hsa-miR-3064-5p Primers
mr0999AdmiRa-rno-mir-3064 Virus
MPM00305mmu-miR-3064-3p Primers
MPR00579rno-miR-3064-3p Primers
MPH02406hsa-miR-3064-3p Primers
MPM00306mmu-miR-3064-5p Primers

Popular Products